Skip to main content
Premium Trial:

Request an Annual Quote

Biotage to Cut 50 Jobs, Transfer Instrument Production

NEW YORK (GenomeWeb News) – Biotage said today that it will transfer its instrument production operations to a contract manufacturer, which will result in 50 jobs being cut from the firm.

The Uppsala, Sweden-based life science tools firm said that it would move its instrument production from its current facilities in Charlottesville, Va., to an unnamed contract manufacturer. The instruments made at that facility are primarily for purification applications. A small portion of the firm's consumables also are made at the Virginia facility, but production of those products will be moved to Biotage's facility in Cardiff, Wales, which already manufactures the majority of its consumables.

"By moving production from Charlottesville, we achieve considerable efficiency gains and reduce susceptibility to changes in demand," Biotage President and CEO Torben Jorgensen said in a statement.

Biotage expects to complete the transfer of production to the contractor by the end of this year.

The firm did not provide an estimate of savings from the outsourcing and job cuts.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.